- Anti-HIV Drug Game
- Treatment & Care
- Treatment & Care
- Introduction to HIV and AIDS
- The immune system and HIV
- Monitoring the immune system
- Genetics and HIV treatment
- Preventing HIV infection
- Ways of attacking HIV
- Starting HIV treatment
- Changing HIV treatment
- Drug resistance
- Side-effects
- Adherence
- Drug interactions and pharmacokinetics
- HIV treatment during pregnancy
- HIV treatment in children
- Treatment guidelines
- A to Z of medical tests
- A to Z of drugs
- Symptoms and illnesses
- HIV Treatment Update
- Factsheets
- Patient Information Booklets
Treatment & Care
The Treatment & Care section of aidsmap.com contains all you need to know about HIV treatment. To find out the answers to your questions, please click on one of the chapters below, or view the Treatment & Care Sitemap.
- Introduction to HIV and AIDS
- The immune system and HIV
- Monitoring the immune system
- Genetics and HIV treatment
- Preventing HIV infection
- Ways of attacking HIV
- Starting HIV treatment
- Changing HIV treatment
- Drug resistance
- Side-effects
- Adherence
- Drug interactions and pharmacokinetics
- HIV treatment during pregnancy
- HIV treatment in children
- Treatment guidelines
- A to Z of medical tests
- A to Z of drugs
- Symptoms and illnesses
latest aidsmap news
- High rate of death amongst patients with HIV diagnosed late
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Raltegravir may have role in PEP if exposure involves drug-resistant HIV
- Excellent outcomes from five years of antiretroviral use in Botswana
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
- If you can't switch, better to stay on failing treatment than stop it, studies show
- Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’